European Nuclear Medicine/Radiopharmaceuticals Market - Forecasts to 2020 - New Study Released

From: Fast Market Research, Inc.
Published: Mon Nov 30 2015


European Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)), by Application (Oncology, Thyroid, Cardiology) - Forecasts to 2020

The European nuclear medicine/radiopharmaceuticals market is segmented on the basis of type, application, and country. The European nuclear medicine/radiopharmaceuticals market is valued at USD 1.095 billion in 2015 and is poised to grow at a CAGR of 8.2% during the forecasted period.

Factors such as increasing preference for SPECT and PET scans, advances in radiotracers, advent of alpha radio immunotherapy-based targeted cancer treatment, increasing incidence & mortality rate of cancer and cardiac ailments are driving the growth of this market. Moreover, potential radioisotopes in the pipeline, cyclotron based production are likely to create huge opportunities for this market in the coming years. However, factors such as shorter half-life of radiopharmaceuticals, competition from conventional diagnostic procedures are hindering the growth of this market.

Full Report Details at
- http://www.fastmr.com/prod/1073540_european_nuclear.aspx?afid=301

Some of the major players in the European nuclear medicine/radiopharmaceuticals market include Cardinal Health Inc. (U.S.), GE Healthcare (U.K.), Bracco Imaging S.p.A (Italy), Eczacibasi-Monrol Nuclear Products (Turkey), Nordion, Inc. (Canada), Advanced Accelerator Applications S.A. (France), Bayer Healthcare (Germany), Lantheus Medical Imaging, Inc. (U.S.), IBA Molecular Imaging (Belgium), and Mallinckrodt plc (Ireland).

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the European market, which in turn helps the firms garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

* Market Penetration: Comprehensive information on the product portfolios offered by the top players in the European nuclear medicine/radiopharmaceuticals market. The report analyzes the European nuclear medicine/radiopharmaceuticals market by type, application, and country
* Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the European nuclear medicine/radiopharmaceuticals market
* Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various European nuclear medicine/radiopharmaceuticals technologies across Europe

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Nuclear Medicine/Radiopharmaceuticals Market - Global Forecasts to 2020
- Acute Myeloid Leukemia Therapeutics Market to 2020 - Novel Therapies to Offer Clinical Benefit in Small Patient Cohorts
- Radiation Detection Monitoring & Safety Market - Trends & Global Forecasts to 2020
- Nuclear Medicine Equipment Market - Global Forecasts to 2020
- MediPoint: Nuclear Imaging - PET and SPECT Equipment - Global Analysis and Market Forecasts

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email: press@fastmr.com
Contact Phone: 1-413-485-7001

Visit website »